問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result

Search Result

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

List

5239Cases

2009-09-01 - 2014-07-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2008-06-01 - 2011-06-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2006-06-01 - 2011-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2006-06-30 - 2007-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Study ended1Sites

2008-09-01 - 2009-12-31

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2013-08-01 - 2015-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2011-05-01 - 2013-04-30

Phase I/II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2018-05-15 - 2021-12-30

Phase I/II

A Phase I/II Dose-Escalation Study of Lipotecan® in Combination with Capecitabine-based Concurrent Chemoradiotherapy (CCRT) as Neoadjuvant Chemoradiotherapy in Patients with Surgically Resectable Locally Advanced Rectal Cancer

  • Condition/Disease

    Colorectal cancer

  • Test Drug

    Lipotecan® (TLC388 HCl for injection)

Participate Sites
4Sites

Terminated3Sites

王照元
Kaohsiung Municipal Gangshan Hospital

未分科

2016-11-01 - 2018-10-20

Phase I/II

A Phase I/II, Dose-escalation Study of Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

  • Condition/Disease

    Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

  • Test Drug

    Lipotecan®; (TLC388 HCl for Injection)

Participate Sites
3Sites

Terminated3Sites

2016-12-01 - 2018-12-31

Phase II

A Phase IIa, Randomized, Double blinded, Placebo-controlled, Dose-finding Study for Single-dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee

  • Condition/Disease

    Osteoarthritis (OA) of Knee

  • Test Drug

    TLC599

Participate Sites
9Sites

Terminated8Sites

張棋楨
Taipei Medical University Hospital

1 483 484 485 486 487 524
聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB